Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach
Author:
Funder
Genentech Inc
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference32 articles.
1. CDC’s National Asthma Control Program Grantees,2013
2. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma;Bousquet;Allergy,2005
3. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children;Busse;N Engl J Med,2011
4. "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study;Brusselle;Respir Med,2009
5. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update;Holgate;Respir Med,2009
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term safety, durability of response, cessation and switching of biologics;Current Opinion in Pulmonary Medicine;2024-03-01
2. Addressing therapeutic inertia for asthma biologics: Lessons from the KOFU study;Respiratory Investigation;2023-11
3. Severe Asthma and Biological Therapies: Now and the Future;Journal of Clinical Medicine;2023-09-08
4. Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey;Expert Review of Respiratory Medicine;2023-06-03
5. Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL;World Allergy Organization Journal;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3